文献速递肿瘤 PET/CT

正电子发射断层显像无创可视化肿瘤微环境pH变化

Non-invasive visualization of pH changes within the tumor-micro-environment by positron emission tomography.
PubMed 文献 · EJNMMI Res · 2026-02-05

研究开发基于糖基胺键pH依赖性水解的PET示踪剂[18F]FDG-4MBA和[18F]FDG-BA,在酸性条件下释放[18F]FDG功能基团,以实现无创成像pH变化。体外实验显示水解呈假一级动力学且pH依赖性,在B16F10和MC38酸性皮下肿瘤模型中[18F]FDG-4MBA较[18F]FDG-BA更好区分酸性TME的pH差异,体内中和酸性细胞外肿瘤pH可阻止pH依赖性裂解并降低PET信号。

要点

  • 糖基胺PET示踪剂利用酸性pH下水解释放[18F]FDG,实现无创pH成像。
  • [18F]FDG-4MBA在体内比[18F]FDG-BA更好区分不同酸性肿瘤的pH差异。
  • 中和肿瘤细胞外酸性pH可减少示踪剂裂解并降低PET信号。

核心结论

  • 糖基胺放射性示踪剂联合PET成像测定酸性TME中的pH差异,可能作为研究pH调节与免疫治疗反应等问题的新型标志物。

研究设计与样本

  • 临床前研究,开发[18F]FDG-4MBA和[18F]FDG-BA两种PET示踪剂,在B16F10和MC38酸性皮下肿瘤模型中进行体外和体内评价。

主要发现

  • NMR显示[19F]FDG-4MBA水解呈假一级动力学,50%裂解时间从pH 7.4的3小时缩短至pH 6.9的60分钟和pH 6.5的45分钟。
  • 在pH 8.3下60分钟内,[18F]FDG-4MBA的FDG释放低于15%,[18F]FDG-BA低于10%。
  • 在酸性pH 6.0下60分钟,[18F]FDG-4MBA释放71% FDG,[18F]FDG-BA释放40% FDG。
  • 体外B16F10或MC38细胞摄取呈pH依赖性,与FDG摄取不同;在B16F10和MC38酸性皮下肿瘤模型中,[18F]FDG-4MBA比[18F]FDG-BA更好区分酸性TME的pH差异。

临床怎么用

  • 该技术有望用于无创评估肿瘤微环境酸化程度,并可能指导pH相关治疗及免疫治疗反应的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acidic pH values of the tumor microenvironment (TME) have crucial effects on metastatic behavior, host defense, immune regulation and cellular metabolism. Several studies have shown that the acidity of the interstitial space in the TME influences the functions of cancer and stromal cells, particularly regarding immune effects. Changing intratumoral pH might therefore be a potential target for therapy, and pH imaging might guide further developments. We describe radiopharmaceutical probes for positron emission tomography (PET) that exploit the concept of pH-dependent intratumoral hydrolysis of glycosylamine bonds of PET-tracers ([18F]FDG-4-methoxybenzylamine ([18F]FDG-4MBA) and [18F]FDG-benzylamine ([18F]FDG-BA)) to release [18F]FDG as functional moiety with the aim to non-invasively image pH changes. RESULTS: Nuclear magnetic resonance (NMR) spectroscopy demonstrated hydrolysis at pseudo first order and showed pH dependent hydrolysis time, at which 50% of [19F]FDG-4-methoxybenzylamine ([19F]FDG-4MBA) was cleaved, ranging from 3 h at pH 7.4 over 60 min at pH 6.9 to 45 min at pH 6.5. Hydrolysis of [18F]FDG-4MBA in human serum at pH 7,6 was similar to comparable pH without serum (below 10% FDG release after 2 h). The glycosylamines [18F]FDG-BA and [18F]FDG-4MBA were relatively stable in vitro at pH 8.3 with less than 15% FDG release from [18F]FDG-4MBA and less than 10% FDG release from [18F]FDG-BA within 60 min. Hydrolysis at acidic pH led to [18F]FDG release at pH 6.0 of 71% from [18F]FDG-4MBA and 40% from [18F]FDG-BA at 60 min. In vitro uptake into B16F10 or MC38 cells was pH dependent in contrast to FDG uptake. In a preclinical model bearing the two different acidic subcutaneous tumors (B16F10 and MC38), pH differences in the acidic TME were better discriminated with [18F]FDG-4MBA than with [18F]FDG-BA. In vivo neutralization of the acidic extracellular tumor pH prevented pH-dependent cleavage of [18F]FDG-4MBA resulting in decrease of PET signal. CONCLUSION: The determination of pH differences by glycosylamines radiotracers and PET imaging in acidic TME may serve as a novel marker for various questions such as interaction of pH regulation and response to immunotherapies. Notably, even small pH differences in the acidic TME of different tumors, in the same in vivo model, could be discriminated.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Brück J, Schauenburg D, Kuan SL, et al. Non-invasive visualization of pH changes within the tumor-micro-environment by positron emission tomography. EJNMMI Res. 2026. PMID: 41644870. doi:10.1186/s13550-026-01383-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。